139 related articles for article (PubMed ID: 21716952)
1. Expression of EGFR and Microvessel Density in Middle Ear Cholesteatoma.
Jin BJ; Min HJ; Jeong JH; Park CW; Lee SH
Clin Exp Otorhinolaryngol; 2011 Jun; 4(2):67-71. PubMed ID: 21716952
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor receptor in human middle ear cholesteatoma.
Hsu YC; Ho KY; Chai CY; Lee KW; Wang LF; Wu SC; Kuo WR; Tsai SM
Kaohsiung J Med Sci; 2003 Oct; 19(10):497-502. PubMed ID: 14620675
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
Li H; Jiang P; Wang L
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
[TBL] [Abstract][Full Text] [Related]
4. [Expression of epidermal growth factor receptor Ki67 and p16 in human middle ear cholesteatoma].
Li S; Zhan H; Peng S
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Nov; 22(21):987-91. PubMed ID: 19157151
[TBL] [Abstract][Full Text] [Related]
5. EGFR expression in acquired middle ear cholesteatoma in children and adults.
Alves AL; Pereira CS; Carvalho Mde F; Fregnani JH; Ribeiro FQ
Eur J Pediatr; 2012 Feb; 171(2):307-10. PubMed ID: 21800041
[TBL] [Abstract][Full Text] [Related]
6. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma.
Ergün S; Zheng X; Carlsöö B
Am J Otol; 1996 May; 17(3):393-6. PubMed ID: 8817015
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor expression in middle ear cholesteatoma.
Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
[TBL] [Abstract][Full Text] [Related]
8. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
9. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.
Schulz P; Bujía J; Holly A; Shilling V; Kastenbauer E
Am J Otolaryngol; 1993; 14(2):82-7. PubMed ID: 8484481
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of placenta growth factor in human middle ear cholesteatoma.
Cho JG; Lim HW; Woo JS; Hwang SJ; Lee HM; Chae SW
Acta Otolaryngol; 2006 Sep; 126(9):900-4. PubMed ID: 16864484
[TBL] [Abstract][Full Text] [Related]
11. [Epidermal growth factor in cholesteatoma--the second report: the localization in the horny layer].
Goto Y
Nihon Jibiinkoka Gakkai Kaiho; 1990 Aug; 93(8):1192-9. PubMed ID: 2231169
[TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in urinary bladder carcinoma as defined by microvessel density (MVD) after immunohistochemical staining for Factor VIII and CD31.
El Gehani K; Al-Kikhia L; Mansuri N; Syrjänen K; Al-Fituri O; Elzagheid A
Libyan J Med; 2011 Mar; 6():. PubMed ID: 21526043
[TBL] [Abstract][Full Text] [Related]
13. Laser-assisted cholesteatoma surgery: technical aspects, in vitro implementation and challenge of selective cell destruction.
Caffier PP; Marzahn U; Franke A; Sudhoff H; Jovanovic S; Haisch A; Sedlmaier B
Eur Arch Otorhinolaryngol; 2008 Oct; 265(10):1179-88. PubMed ID: 18253741
[TBL] [Abstract][Full Text] [Related]
14. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis.
Broekaert D; Cornille A; Eto H; Leigh I; Ramaekers F; Van Muijen G; Coucke P; De Bersaques J; Kluyskens P; Gillis E
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):39-51. PubMed ID: 2453971
[TBL] [Abstract][Full Text] [Related]
15. Expression of RANKL and OPG in middle ear cholesteatoma tissue.
Jeong JH; Park CW; Tae K; Lee SH; Shin DH; Kim KR; Park YW
Laryngoscope; 2006 Jul; 116(7):1180-4. PubMed ID: 16826057
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
[TBL] [Abstract][Full Text] [Related]
17. [The expressions and correlations of RAR-beta receptors and galectin-8 in human middle ear cholesteatoma].
Peng L; Cui Y; Liu A
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 18(7):427-9. PubMed ID: 15499989
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the expression of involucrin, filaggrin and cytokeratin 4, 10, 16 in cholesteatoma.
Min HJ; Park CW; Jeong JH; Cho SH; Kim KR; Lee SH
Korean J Audiol; 2012 Dec; 16(3):124-9. PubMed ID: 24653886
[TBL] [Abstract][Full Text] [Related]
20. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
